CNV detection in cancer sample can be done based on either mapping distance of paired-end reads or read depth. However, The mapping distance strategy is not able to detect CNV in case of aneuploidy, right? Because aneuploidy produces CNV while the mapping distance of paired-end reads on each chromosome still remain unchanged. Does this mean the read depth strategy is better since it cover both situation? Can someone share some insight?
Maybe important to add that in whole-exome data, because you only sequence 1-2% of the genome, you don't see most of the breakpoints directly. So you are pretty much left with read-pileups.
Then there is unfortuantely a huge variance in quality of whole-exome data. Great sequencing centers get coverage now fairly even and you get clean somatic copy number calls out of high quality data. Garbage in, garbage out.